BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cuitavi J, Hipólito L, Canals M. The Life Cycle of the Mu-Opioid Receptor. Trends Biochem Sci 2021;46:315-28. [PMID: 33127216 DOI: 10.1016/j.tibs.2020.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Omidian H, Babanejad N, Omidi Y. Opioid epidemic and the urge to discover new treatment options. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.05.025] [Reference Citation Analysis]
2 Jaschke N, Pählig S, Pan YX, Hofbauer LC, Göbel A, Rachner TD. From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks. Trends Endocrinol Metab 2021;32:306-19. [PMID: 33676828 DOI: 10.1016/j.tem.2021.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cuitavi J, Lorente JD, Campos-Jurado Y, Polache A, Hipólito L. Neuroimmune and Mu-Opioid Receptor Alterations in the Mesocorticolimbic System in a Sex-Dependent Inflammatory Pain-Induced Alcohol Relapse-Like Rat Model. Front Immunol 2021;12:689453. [PMID: 34616393 DOI: 10.3389/fimmu.2021.689453] [Reference Citation Analysis]
4 Gadais C, Piekielna-Ciesielska J, De Neve J, Martin C, Janecka A, Ballet S. Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist-Neurokinin Antagonist Peptidomimetics. Molecules 2021;26:5406. [PMID: 34500841 DOI: 10.3390/molecules26175406] [Reference Citation Analysis]
5 Udayakumar P, Udayakumar S. Fentanyl-Induced Respiratory Depression: A Narrative Review on the Possible Single-Nucleotide Polymorphism. Anesth Essays Res 2021;15:4-7. [PMID: 34667340 DOI: 10.4103/aer.aer_94_21] [Reference Citation Analysis]
6 Lešnik S, Bertalan É, Bren U, Bondar AN. Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs. Int J Mol Sci 2021;22:13353. [PMID: 34948150 DOI: 10.3390/ijms222413353] [Reference Citation Analysis]
7 Chakraborty S, Uprety R, Daibani AE, Rouzic VL, Hunkele A, Appourchaux K, Eans SO, Nuthikattu N, Jilakara R, Thammavong L, Pasternak GW, Pan YX, McLaughlin JP, Che T, Majumdar S. Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom. ACS Chem Neurosci 2021;12:2661-78. [PMID: 34213886 DOI: 10.1021/acschemneuro.1c00149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
8 Chakraborty S, DiBerto JF, Faouzi A, Bernhard SM, Gutridge AM, Ramsey S, Zhou Y, Provasi D, Nuthikattu N, Jilakara R, Nelson MNF, Asher WB, Eans SO, Wilson LL, Chintala SM, Filizola M, van Rijn RM, Margolis EB, Roth BL, McLaughlin JP, Che T, Sames D, Javitch JA, Majumdar S. A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects. J Med Chem 2021;64:13873-92. [PMID: 34505767 DOI: 10.1021/acs.jmedchem.1c01273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jaschke N, Sipos W, Hofbauer LC, Rachner TD, Rauner M. Skeletal endocrinology: where evolutionary advantage meets disease. Bone Res 2021;9:28. [PMID: 34050126 DOI: 10.1038/s41413-021-00149-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Deng M, Zhang Z, Xing M, Liang X, Li Z, Wu J, Jiang S, Weng Y, Guo Q, Zou W. LncRNA MRAK159688 facilitates morphine tolerance by promoting REST-mediated inhibition of mu opioid receptor in rats. Neuropharmacology 2022;206:108938. [PMID: 34982972 DOI: 10.1016/j.neuropharm.2021.108938] [Reference Citation Analysis]
11 Petit-Pedrol M, Groc L. Regulation of membrane NMDA receptors by dynamics and protein interactions. J Cell Biol 2021;220:e202006101. [PMID: 33337489 DOI: 10.1083/jcb.202006101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]